인쇄하기
취소

The Samsung’s global biosimilar project is about to bear fruit

Published: 2015-07-08 14:00:23
Updated: 2015-07-08 14:00:23

The global biosimilar project of Samsung is about to bear fruit. This is because its product commercialization prepared by technologies and funds of Bioepis and Biologics has been visualized.

It is expected that the Samsung’s biosimilar development will impact not only the domestic bio field but the entire pharmaceutical industry.

Samsung has expanded its position in the market by operating B...

Fees

- Email service daily and homepage access.
  1. $300 per month.
  2. 5 Email holders per each company.
  3. Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.